CenExel Acquires Apex Innovative Sciences from Bison Capital
June 16, 2022
CenExel Clinical Research has acquired Apex Innovative Sciences, Inc. from Bison Capital Partners V, LP. The transaction adds Apex’s CNS-focused clinical research sites (including Collaborative Neuroscience Research and Hassman Research Institute) — five centers across California and New Jersey with substantial early‑phase and inpatient capacity — expanding CenExel’s neuroscience capabilities and geographic footprint.
- Buyers
- CenExel Clinical Research, Inc. (CenExel)
- Targets
- Apex Innovative Sciences, Inc., Collaborative Neuroscience Research (CNS), Hassman Research Institute (HRI)
- Sellers
- Bison Capital Partners V, LP
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
BayPine to Acquire CenExel Clinical Research
April 14, 2025
Healthcare Services
BayPine entered into a definitive agreement to acquire CenExel Clinical Research, a nationwide clinical trial site network focused on complex therapeutic areas. After closing, BayPine will be the majority investor in CenExel alongside Webster Equity Partners, which will retain a minority stake, with management continuing to hold equity.
-
CenExel Acquires iResearch
May 3, 2022
Healthcare Services
CenExel, a Salt Lake City–based clinical research site network, acquired iResearch, a multi-specialty clinical research site with locations in Decatur and Savannah, Georgia. The deal strengthens CenExel's CNS (psychiatry and neurology) and dermatology trial capabilities while expanding its patient reach in the Atlanta metro and throughout Georgia.
-
CenExel Clinical Research Acquires California Neuroscience Research
January 10, 2022
Healthcare Services
CenExel Clinical Research, a Salt Lake City–based clinical research site network, has acquired California Neuroscience Research, a Los Angeles area neurology and psychiatry clinical research facility led by Dr. Tom Shiovitz. The acquisition strengthens CenExel's central nervous system (CNS) trial capabilities and expands its patient reach in the Los Angeles market.
-
CenExel Clinical Research Acquires Advanced Memory Research Institute
August 19, 2021
Healthcare Services
CenExel Clinical Research, Inc. has acquired Advanced Memory Research Institute (CenExel AMRI), the largest Alzheimer's Disease clinical research site in the U.S. Northeast. The deal expands CenExel's CNS and Alzheimer's trial capabilities by integrating AMRI into its Centers of Excellence network; Provident Healthcare Partners served as exclusive sell-side financial advisor.
-
CenExel Clinical Research Acquires CITrials
March 9, 2021
Healthcare Services
CenExel Clinical Research, a U.S.-based network of clinical research sites, has acquired CITrials, a Southern California clinical research firm operating three sites serving Los Angeles, Orange, and Riverside/San Bernardino counties. The acquisition expands CenExel's capacity and capabilities in psychiatric and neurological (CNS) research and enables greater integration with its other Southern California operations.
-
Bison Capital Invests in Apex Innovative Sciences, Forming a National Clinical Trial Site Network
October 2, 2019
Healthcare Services
Bison Capital Partners V, LP announced a growth capital investment to form Apex Innovative Sciences, Inc., combining CNS Network and Hassman Research Institute and acquiring Clinical Trial Centers Alliance to create a national operator of clinical trial sites focused on central nervous system (CNS) indications. The new company operates multiple clinical research sites and Ocean View Psychiatric Hospital (a 36‑bed acute psychiatric hospital) to support Phase I–IV studies for pharmaceutical and biotech sponsors.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.